Read more

March 01, 2022
2 min read
Save

20% of girls with type 2 diabetes have PCOS, meta-analysis finds

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Approximately one in five girls with type 2 diabetes have polycystic ovary syndrome, according to findings of a meta-analysis in JAMA Network Open.

Perspective from Marisa Censani, MD

PCOS is a complex endocrine disorder that occurs in 1.14% to 11.04% of adolescent girls globally,” Milena Cioana, BHSc, of the department of pediatrics at McMaster University and the division of pediatric endocrinology at McMaster Children’s Hospital in Ontario, Canada, and colleagues wrote.

Data derived from Cioana M, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2021.47454.
Data derived from Cioana M, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2021.47454.

“However, although PCOS is associated with a range of conditions that are related to obesity, the association of PCOS with obesity is not well understood,” they added. “PCOS is more common in adolescents with obesity, yet insulin resistance is at times present in patients with PCOS regardless of their BMI.”

Cioana and colleagues reviewed databases for literature up until April 4, 2021. They included studies for analysis if they:

  • reported PCOS in girls who were diagnosed with type 2 diabetes at 18 years of age or younger;
  • were cross-sectional, retrospective or prospective by design;
  • had a sample size of at least 10 patients; and
  • reported the prevalence of PCOS in patients with diabetes.

The researchers assessed the appropriateness and quality of the data using the Oxford Centre for Evidence-Based Medicine criteria.

The final analysis included six cohort studies — five retrospective and one prospective — involving 470 girls with diabetes (mean age at diabetes diagnosis, 12.9 to 16.1 years). Among all participants, 19.58% (95% CI, 12.02%-27.14%) had PCOS, which was defined as “persistent oligomenorrhea and clinical and/or biochemical hyperandrogenism” in three studies and was unclear in the others.

In the two studies reporting PCOS prevalence by race, 36 (17%) white girls, 195 (23.1%) Indian girls and 64 (2%) Indigenous girls in Canada had PCOS.

“On the basis of studies with mostly moderate risk of bias, this systematic review and meta-analysis demonstrated that approximately one in five girls with [diabetes] have PCOS,” they wrote. “This figure is substantially higher than PCOS prevalence among the general female adolescent population.”

However, the meta-analysis was limited because some of the studies failed to establish diagnostic criteria for PCOS and did not report the time of menarche. Also, none of the studies used PCOS as a primary outcome.

“Given these limitations, the results should be interpreted with caution,” Cioana and colleagues wrote. “Larger multiethnic, longitudinal cohort studies evaluating PCOS prevalence in girls with [diabetes] and using standardized criteria for defining PCOS are urgently needed.”